Labshake search
Citations for Peprotech :
201 - 250 of 2377 citations for IL 1RA Human HEK293 since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Microbiology 2020Quote: ... and a Human IL-8 Standard TMB ELISA Development Kit (PeproTech, catalog number 900-T18), according to manufacturer’s instructions ...
-
bioRxiv - Cell Biology 2021Quote: ... murine IL-3 (213-13) and Recombinant Human EPO (100-64) were obtained from PeproTech.
-
bioRxiv - Microbiology 2020Quote: Dividing THP-1 cells were treated with 10 ng/mL recombinant human IL-1β (Peprotech) for the times indicated ...
-
bioRxiv - Genomics 2021Quote: ... in a 3:1 beads:cells ratio and 100 U/mL recombinant human IL-2 (Peprotech).
-
bioRxiv - Immunology 2020Quote: ... M2c cells with 25 ng/mL recombinant human IL-10 (PeproTech; Rock Hill, NJ, USA); and M2d MΦs from stimulation with and 50 ng/mL recombinant human IL-6 (R&D Systems ...
-
bioRxiv - Immunology 2022Quote: ... cells were cultured in complete RPMI containing recombinant human IL-2 (30 U/ml, Peprotech) and stimulated with anti-CD3/anti-CD28 Dynabeads (Invitrogen ...
-
bioRxiv - Immunology 2022Quote: ... Monocytes were cultured in cRPMI supplemented with recombinant human IL-4 and GM-CSF (Peprotech) to generate immature monocyte-derived dendritic cells (Mo-DCs) ...
-
bioRxiv - Immunology 2022Quote: ... in the absence or presence of human recombinant (hr) IL-1β (10 ng/mL, Peprotech) and hrIL-23 (20 ng/mL ...
-
bioRxiv - Immunology 2022Quote: ... We further supplemented the media with 5 ng/mL recombinant human (rh) IL-2 (Peprotech) and 10 ng/mL rhIL-7 ...
-
bioRxiv - Cell Biology 2024Quote: ... BMP-2/4) (ERB medium)3 or adding 10 ng/ml human IL-22 (Peprotech) in WENRA4 (Wnt/ R-spondin1 ...
-
bioRxiv - Systems Biology 2023Quote: ... and subsequently cultured in complete culture media supplemented with 5 nM human IL-2 (Peprotech) for up to 10 days ...
-
bioRxiv - Physiology 2023Quote: ... Recombinant Human TNF-α (300-01A) and IL-1β (200-01B) were acquired from PeproTech. DAPI (4’,6-diamidino-2-phenylindole ...
-
bioRxiv - Immunology 2024Quote: ... recombinant human IL-2 (20 ng/mL) and recombinant mouse IL12 (2 ng/mL) (Peprotech) for 2 days ...
-
bioRxiv - Systems Biology 2020Quote: ... at concentrations 0-10 ng/mL or recombinant human interleukin 10 (IL-10, PeproTech, #200-10) at concentrations 0-1000 ng/mL for 30 min ...
-
bioRxiv - Immunology 2022Quote: ... The monocytes were cultured in cRPMI supplemented with recombinant human IL-4 and GM-CSF (Peprotech) to induce DC differentiation ...
-
bioRxiv - Bioengineering 2019Quote: ... IL-15 and IL-2 (Peprotech).
-
bioRxiv - Cancer Biology 2020Quote: ... IL-3 and IL-6 (PeproTech 300-07 ...
-
bioRxiv - Genomics 2021Quote: ... IL-3 and IL-6 (PeproTech). After 48 hours culture ...
-
bioRxiv - Immunology 2019Quote: ... 100 IU/mL recombinant human (rh) IL-2 (Proleukin, Novartis) and 10 ng/mL rhIL-15 (Peprotech), and were cultured in a humidified incubator at 37 °C + 5% CO2 ...
-
bioRxiv - Biochemistry 2020Quote: scFv-ribosome-mRNA complexes were subjected to selection in solution using recombinant biotinylated human IL-13 (Peprotech) to allow capture using streptavidin-coated paramagnetic beads (Dynabeads M-280) ...
-
bioRxiv - Immunology 2022Quote: ... 14 d IL-2/IL-15 activated human NK cells were plated with K562 leukemia cells at an effector:target (E:T) ratio of 2.5:1 in addition to human IL-2 (100 IU/mL, Peprotech), human IL-15 (20 ng/mL ...
-
bioRxiv - Immunology 2019Quote: ... and 100 μm non-essential amino acids) with 100 U/ml of recombinant human IL-2 (PeproTech), which was replaced every 2 days keeping the cells at a concentration of 1.5 × 106 cells/ml ...
-
bioRxiv - Cancer Biology 2022Quote: ... recombinant human IL-2 (rhIL-2, final concentration of 20 ng/mL; Peprotech, Cat# 200-02-1mg), and 2-mercaptoethanol to a final concentration of 0.05mM (Gibco ...
-
bioRxiv - Immunology 2024Quote: ... and 0.5 µg/mL anti-mouse CD28 (eBioscience) and recombinant human IL-15 (20 ng/mL, Peprotech) or recombinant human IL-2 (20 ng/mL ...
-
bioRxiv - Bioengineering 2019Quote: ... Inflammatory (INF) media consisted of culture media described above supplemented with human recombinant IL-1β (500pg/ml; PeproTech) and TNF-α (400pg/ml ...
-
bioRxiv - Immunology 2021Quote: ... 5µM CHK2 kinase inhibitor II) and 50 ng/ml of recombinant human (rHu) IL-21 (200-21; Peprotech) in RPMI/15% fetal calf serum ...
-
bioRxiv - Neuroscience 2022Quote: ... and supplemented with 3 growth factors (GFs): 100ng/mL human recombinant interleukin-34 (IL-34; Peprotech # 200-34), 25ng/mL macrophage colony-stimulating factor (M-CSF ...
-
bioRxiv - Systems Biology 2020Quote: ... AO’s were stimulated with 0.02 μg/ml of human IL-1β Invivogen or 0.1 μg/ml of IFNγ (PeproTech) for 48 h ...
-
bioRxiv - Immunology 2021Quote: ... diluted in complete RPMI (cRPMI; RPMI supplemented with 10% FBS plus recombinant human IL-2 (20IU/ml; Peprotech), as previously described.65,66 Activated cells were incubated for six days with a media change on day three.
-
bioRxiv - Immunology 2021Quote: ... whole bone marrow was plated at 1M cells/mL in cRPMI + 400U/mL Proleukin human IL-2 (Peprotech). Fresh IL-2 was added every 3rd day ...
-
bioRxiv - Immunology 2021Quote: ... For TH17 cell differentiation, IL-6 (eBioscience, 20 ng/mL) and human TGF-β1 (Peprotech, 0.3 ng/mL) were added ...
-
bioRxiv - Immunology 2021Quote: ... Inducers of neutrophil chemotaxis were added to the bottom well in 600 µL of RPMI-1640 media containing 1,000 or 50,000 pg of recombinant human (rh-) IL-8 (PeproTech) or A549 cells culture previously infected for 48 hours with mock or ZIKV PE243 (1 MOI) ...
-
bioRxiv - Immunology 2022Quote: ... Approximately 2.5×105 TDM and MDM were stimulated with recombinant human IL-6 (200 or 2000 pg, Peprotech) for 24 hours at 37ºC and 5% CO2 ...
-
bioRxiv - Immunology 2022Quote: ... seeded at a density of 0.5×106/mL and stimulated with 0.5 or 25 ng/ml recombinant human IL-15 (PeproTech,). After an overnight period ...
-
bioRxiv - Immunology 2023Quote: ... and expanded in RPMI 1640 containing 10% FBS and 100 IU/mL of recombinant human IL-2 (Peprotech). Human blood samples were enriched for T cells using negative bead selection (StemCell ...
-
bioRxiv - Bioengineering 2024Quote: ... 20 ng/mL interleukin-4 (IL-4) and 50 ng/mL recombinant human M-CSF (Peprotech EC Ltd.) were added to the culture media for 24 hours ...
-
bioRxiv - Immunology 2021Quote: IL-4 or IL-13 (Biolegend or PeproTech) was added into macrophage cultures at various concentrations to induce the M2/M2a phenotype in the presence or absence of a soluble CD47 extracellular domain (mCD47.ex or hCD47.ex) ...
-
bioRxiv - Immunology 2019Quote: ... Recombinant murine cytokines (IL-3, IL-5, IL-9, GM-CSF, SCF) were from Peprotech.
-
bioRxiv - Pathology 2023Quote: ... or 5 ng/mL of recombinant murine interleukin (IL) −4 and −13 (IL-4, IL-13) (ILs) (PeproTech 214-14, 210-13), were added to the serum-free media ...
-
bioRxiv - Biochemistry 2020Quote: ... according to the manufacturer’s instructions and cultured in RPMI supplemented with 10% FBS and 30 U/ml recombinant human IL-2 (PeproTech) at 37°C in 5% CO2 ...
-
bioRxiv - Cancer Biology 2022Quote: ... with sorted autologous TFH cells (at a 1:1 ratio) or TFH mimicking signals (including 0.02 μg/mL recombinant human IL-4, Peprotech; 0.05 μg/ml recombinant human IL-21 ...
-
bioRxiv - Immunology 2021Quote: ... Switzerland) for 11 days in the human plasma serum-containing medium with 3000 IU/ml of IL-2 (PeproTech). The cell cultures were supplemented with fresh media and IL-2 every 2–4 days ...
-
bioRxiv - Immunology 2021Quote: ... at a bead to cell ratio of 3:1 and 1,000 U/mL of recombinant human IL-2 (Peprotech). Fresh IL-2 containing media was added every 48 h and Human T-activator CD3/CD28 Dynabeads were added again at day 7 and removed at day 15 of expansion ...
-
bioRxiv - Cell Biology 2022Quote: ... cells were exposed to different dose-course or time-course of human IL-22 (Peprotech, Rocky Hill, NJ, USA). In order to study the rescue effecting ...
-
bioRxiv - Genetics 2022Quote: ... clone 145-2C11, WEHI antibody facility), anti-CD28 (2μg/ml, clone 3751, WEHI antibody facility) and human IL-2 (Peprotech). CD8 T cell cultures contained 25μg/ml anti-mouse IL2 (clone S4B6 ...
-
bioRxiv - Immunology 2024Quote: CD8 T cells from WT p14 or Irf5-/- p14 mice were isolated as described above and cultured with or without 1µg/ml gp33 peptide in complete RPMI medium supplemented with 2ng/ml recombinant human IL-2 (Peprotech). Cells were then collected at 6 or 24 hours after incubation and washed with PBS ...
-
bioRxiv - Microbiology 2022Quote: ... monocytes were differentiated into imDCs in the presence of human interleukin 4 (IL-4; 20ng/ml; PEPROTECH; 200-04) and human granulocyte-macrophage colony-stimulating factor (GM-CSF ...
-
bioRxiv - Immunology 2023Quote: ... in the presence of 2mg/mlaCD28 (clone 37.51, WEHI antibody facility) and 100U/ml recombinant human IL-2 (Peprotech), in 96 well flat-bottom plates at 104 cells per well ...
-
bioRxiv - Immunology 2020Quote: ... or IL-15Rα pre-complexed with IL-15 (Peprotech) was added ...
-
bioRxiv - Immunology 2021Quote: ... IL-2 and IL-12 were obtained from PeproTech. In vivo antibodies anti-PD-1 (clone J43) ...